Topics

Glioblastoma | Diagnosis | Positron emission tomography

Home > Publications > Topics > Glioblastoma > Diagnosis > Positron emission tomography

Lakomý R, Lojová M, Souckova L, Hynkova L, Polachova K, Vasina J, Demlová R, Poprach A, Sana J, Prochazka T, Smrcka M, Fadrus P, Jancalek R, Selingerova I, Belanova R, Slampa P, Pospisil P, Kazda T.
¹¹C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET).
BMC Cancer. 2024 Jun 15;24(1):736. doi: 10.1186/s12885-024-12469-2. PMID: 38879476. Interventional study protocol. ˍ

Sipos D, Debreczeni-Máté Z, Ritter Z, Freihat O, Simon M, Kovács Á.
Complex Diagnostic Challenges in Glioblastoma: The Role of ¹⁸F-FDOPA PET Imaging.
Pharmaceuticals (Basel). 2024 Sep 15;17(9):1215. doi: 10.3390/ph17091215. PMID: 39338377. Review. ˍ

Optimal biopsy target region

Kawauchi D, Ohno M, Sugino H, Ito K, Fuse K, Yoshida A, Kubo Y, Honda-Kitahara M, Yanagisawa S, Ohmura T, Aoki T, Kawanishi A, Sakuramachi M, Igaki H, Narita Y.
Utility of [18F]fluciclovine PET/MRI for identifying the optimal biopsy target region, helping to avoid underdiagnosis in patients with glioblastoma: illustrative case.
J Neurosurg Case Lessons. 2025 Mar 3;9(9):CASE24677. doi: 10.3171/CASE24677. PMID: 40030156. Case report. ˍ